Anti-HB-EGF (human) antibody, monoclonal (4G10)

Product#: 71-501
$375.00
Availability:
Ships in 1-2 weeks

Anti-HB-EGF (human) antibody, monoclonal (4G10)


General Information 
 
Cat. No. :71-501
Size :50 µg
Antigen :Recombinant human HB-EGF ectodomain expres Antigen sed in SF21 cell
Antibody :Produced in serum-free medium and purifie Antibody d by combination of chromatography
Isotype :IgG (Mouse)
Epitope :EGF domain
Host Species :Mouse
Form :Biotinylated IgG (biotin/IgG = 7.5) 1 mg/ml i Form n PBS, 50% glycerol, filter-sterilized, azide-free
Label :Unlabeled
Reactivity :React with human, but not with mouse
Application :IC,IF,IP,Western Blot
Storage :-20°C
Data Link :UniProtKB/Swiss-Prot Data Link Q99075(HBEGF_HUMAN)

Description

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is synthesized as a membrane-bound precursor and cleaved by protease to produce a soluble mature growth factor, HB-EGF ( References 1 and 2). The former works as a juxtacrine growth factor and the latter works as a paracrine growth factor. Soluble HB-EGF has various molecular weights of 19-27 kDa in Western blotting due to heterogeneous O-glycosylation and N-terminal truncation.

HB-EGF activates EGFR and ErbB4 and promotes differentiation in many tissues. In humans, Pro HB-EGF is a cell surface receptor for diphtheria toxin (Reference 3). CRM197, a non-toxic mutant of diphtheria toxin, inhibits the function of HB-EGF. Since HB-EGF is highly expressed in most ovarian cancers, CRM197 has been tried as an anticancer agent (Reference 4). Hybridoma clone 4G10 was created in the laboratory of Prof. Mekada, Osaka University (References 3 and 4).
 
Figure Identification of human HB-EGF by using anti-HB-EGF (clone 4G10)

(a) Western blotting
Sample 1: Vero cell extract
Sample 2: Vero cells carrrying human HB-EGF expression vector
Sample 3: Vero cells carrying mouse HB-EGF expression vector

(b) Immunoprecipitation
Samples are the same as (a) except that the cell surface was biotinylated.

(c) Immuno-cytochemistry
Samples; (Vero-H) Vero cells carrying human HG-EGF expression vector, (Vero-mH) Vero cells carrying mouse HB-EGF expression vector. Cells treated with antibody 4G10 were fixed with 4% PFA and reacted with Cys3 conjugated 2nd antibody
Anti-HB-EGF.png
 
References
 
1. Higashiyama S et al “A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF” Science 251: 936-939 (1991) PMID: 1840698
2. Prenzel N et al “EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF”Nature 402: 884 -888 (1999) PMID: 10622253
3. Iwamoto R et al “Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity” EMBO J 13: 2322-2330 (1994) PMID: 8194524
4. Miyamoto S et al “Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy” Cancer Res 64:5720-5727 (2004) PMID: 15313912


Aliases for HBEGF Gene

  • Heparin Binding EGF Like Growth Factor 2 3 5
  • Diphtheria Toxin Receptor (Heparin-Binding Epidermal Growth Factor-Like Growth Factor) 2 3
  • Diphtheria Toxin Receptor (Heparin-Binding EGF-Like Growth Factor) 2 3
  • Proheparin-Binding EGF-Like Growth Factor 3 4
  • Heparin-Binding Epidermal Growth Factor 2 3
  • HEGFL 3 4
  • DTR 3 4
  • DTS 3 4
  • Heparin-Binding EGF-Like Growth Factor 2
  • HBEGF 5
  • DTSF 3
 
Logo_BioAcademia.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X